Note: Due to COVID-19, some 2020 data may be delayed.
Note: We update this information every month.
Note: Here we use data from Rhode Island Department of Health (RIDOH), Substance Abuse and Mental Health Services Administration (SAMHSA), and Rhode Island Dept of Behavioral Healthcare, Developmental Disabilities and Hospitals (BHDDH).
The number of Rhode Islanders on medication assisted treatment (MAT) is on the rise
Buprenorphine/naloxone, naltrexone, and methadone are evidence-based treatments for opioid addiction (also called opioid use disorder). A key initiative under the Governor’s action plan is to increase the number of people accessing medication assisted treatment (MAT). Learn more about our action plan to address addiction and overdose in Rhode Island.
Buprenorphine treatment capacity in Rhode Island has more than doubled since 2014
Rhode Island has increased the number of trained and data-waivered practitioners who are able to prescribe buprenorphine.
Medication assisted treatment options are available throughout Rhode Island
Find a treatment provider in your community on our Find Treatment page.
